Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Perspectives

  3. Reaping the benefits of digitalization in the lab
Laboratory diagnostics

Reaping the benefits of digitalization in the lab

To meet increasing test volumes, Dr. Lal Pathlabs typically added more instruments. Today, this high-volume reference network in India has a different solution.
5min
Doris Pischitz
Published on July 24, 2023

Dr. Lal Pathlabs, one of India’s most prolific diagnostic laboratories, wanted to consolidate its test menu, improve turnaround times (TAT), and reduce manual work. The team used process automation and integrated information technology (IT) to scale operations while maintaining high standards of accuracy.

Dr. Lal Pathlabs operates almost 2,000 labs and service centers of various sizes across India.

The new setup of the national reference lab

Fast benefits during COVID-19

Workload per analyzer line prior to workload optimization through intelligent TLA.
Workload processed by Atellica Solution lines before ...

Reducing hands-on work

Improvements in turnaround time

Mean TAT was reduced by 59%. In the 95th percentile, TAT was reduced by 57%.

Total lab automation cut TAT by more than half.

Reductions in aliquoting

Dr. LalPath labs achieved 93% reduction in sample splitting. 97% of tests don’t need aliquoting.

Aptio Automation and Atellica Data Manager drive significant reductions in sample splitting.

Lower specimen volume needed

QNS errors decreased by 34%.

QNS errors decreased significantly.

Quality control and result management made easy

Thanks to TLA, autoverified samples increased by 73%.

Autoverified samples increased by 73 percent.

Shaping healthcare in 2023 and beyond
Key visual for Siemens Healthineers Shape 23 Keynote

November 14, 2022

Siemens Healthineers Shape 23 Keynote

Online

Join us and hear some of the world’s most respected healthcare leaders share insights into how to address the challenges posed by cancer, how high-quality care can be brought to more patients, and how to address the workforce crisis.
Watch now
By Doris Pischitz
Doris Pischitz is an editor in corporate communications at Siemens Healthineers. The team specializes in topics related to healthcare, medical technology, disease areas, and digitalization.

Read more

Harnessing digital technology for laboratory diagnostics

  1. 1Product availability varies by country.


    Atellica and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. All other trademarks and brands are the property of their respective owners.

    Aptio Automation is manufactured by Inpeco and is exclusively distributed by Siemens Healthcare Diagnostics Inc. Aptio is a trademark of Siemens Healthcare Diagnostics Inc. Inpeco is a trademark of Inpeco SA.


    The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.